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Upon oral infection, Trypanosoma cruzi metacyclic trypomastigotes invade and replicate in the gastric
mucosal epithelium, being apparently uniquely specialized for adhesion to mucin and mucosal invasion. Here
we investigated the involvement of gp82, the metacyclic-stage-specific surface glycoprotein implicated in host
cell entry, in both adhesion to gastric mucin and invasion of the mucosal epithelium upon oral challenge.
Metacyclic forms, preincubated with a control monoclonal antibody (MAb) or with MAb 3F6 directed to gp82,
were administered orally to BALB/c mice, and parasitemia was monitored. Mice that received parasites treated
with MAb 3F6 had greatly reduced parasitemia, displaying at the peak a mean number of blood parasites more
than 100-fold lower than that of the control group. MAbs directed to other T. cruzi surface glycoproteins had
no such effect. gp82, as either a native or a recombinant molecule, but not the metacyclic trypomastigote
surface molecule gp90 or gp35/50, bound to gastric mucin in enzyme-linked immunosorbent assays. MAb 3F6
significantly inhibited the penetration of cultured epithelial HeLa cells by metacyclic forms in the absence or
in the presence of gastric mucin. Mucin alone did not affect parasite internalization. Parasite infectivity was
not altered by treatment of metacyclic forms with pepsin, to which gp82 was resistant, or with proteinase K,
which removed the N-terminal portion of gp82 but preserved its host cell binding site. Taken together, these
findings suggest that gp82 mediates the interaction of metacyclic trypomastigotes with gastric mucin and the
subsequent penetration of underlying epithelial cells.
Trypanosoma cruzi, the protozoan parasite that causes Cha-
gas’ disease and is transmitted by bloodsucking triatomine in-
sects, can also infect people orally and by blood transfusion.
More than half of the acute cases of Chagas’ disease recorded
between 1968 and 2000 in the Brazilian Amazon were attrib-
utable to microepidemics of orally transmitted infection from
contaminated food (3). Potential sources of food contamina-
tion are whole triatomine insects or their feces containing
infective metacyclic trypomastigotes and possibly the anal
gland secretion of T. cruzi-infected opossums (3), which are
important wild reservoirs of the parasite. Metacyclic trypomas-
tigotes, typically present in the intestinal lumen of the insect
vector, are also found in the lumen of the marsupial anal
glands, where the parasite goes through an extracellular cycle
corresponding to that in the triatomines (4). Oral transmission
through contaminated food in a region with a high rate of T.
cruzi-infected opossums has been reported (15).
Metacyclic trypomastigotes can invade and replicate in the
gastric mucosal epithelium, and it appears that gastric mucosal
invasion is the unique portal of entry for systemic T. cruzi
infection after oral challenge (7). It has been shown that insect-
derived metacyclic trypomastigotes delivered orally were suf-
ficient for consistent infection of 100% of BALB/c mice,
whereas blood form trypomastigotes were found to initiate
mucosal infection rarely, suggesting that metacyclic forms have
uniquely specialized functions for mucosal invasion (6). They
may be resistant to proteolytic enzymes present in mucosal
secretion, and the possibility has been raised that metacyclic
forms express stage-specific surface molecules not present on
blood trypomastigotes, which are required for adhesion to mu-
cosal epithelial surface receptors or for the penetration of
mucin, the protective secreted coat that lines mucosal surfaces
(6).
A metacyclic-stage-specific surface molecule that could be
involved in invasion of epithelial cells of the gastric mucosa is
gp82. This glycoprotein, identified by MAb 3F6 in metacyclic
trypomastigotes but not in blood trypomastigotes, epimastig-
otes, or amastigotes (18), has been implicated in T. cruzi pen-
etration of cultured mammalian cells (10). gp82 is an adhesion
molecule that binds to epithelial cells in a receptor-mediated
manner and induces Ca2 mobilization (11), which is an es-
sential requirement for T. cruzi entry into host cells (5, 9, 17).
In addition to the role of gp82 in mucosal infection upon oral
challenge, it remains to be determined whether gp82 adheres
to gastric mucin and to what extent the action of proteolytic
enzymes digests gp82 and affects the infectivity of metacyclic
forms. To address these questions, in this study, we performed
in vivo and in vitro experiments with T. cruzi metacyclic trypo-
mastigotes obtained in axenic cultures.
T. cruzi isolate CL, from the insect Triatoma infestans (2),
was used. Parasites were maintained alternately in mice and in
liver infusion tryptose medium. Grace’s medium was used to
obtain cultures enriched in metacyclic trypomastigotes, which
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were purified by passage through a DEAE-cellulose column as
previously described (18). For oral infection, metacyclic forms
were introduced by the intrapharyngeal route into 4- to
6-week-old female BALB/c mice through a plastic tube
adapted to a 1-ml plastic syringe. Parasitemia was monitored
by examining 5-l peripheral blood samples under a phase-
contrast microscope. HeLa cells, human carcinoma-derived
epithelial cells, were grown at 37°C in Dulbecco’s minimal
essential medium supplemented with 10% fetal calf serum,
streptomycin (100 g/ml), and penicillin (100 U/ml) in a hu-
midified 5% CO2 atmosphere. Mammalian cell invasion assays
were performed essentially as previously described (19), at a
parasite-to-HeLa cell ratio of 10:1. Native gp82 was purified by
antibody affinity Sepharose column chromatography from de-
tergent-solubilized extracts of metacyclic trypomastigotes (20).
Recombinant proteins J18, comprising the full-length gp82
sequence in frame with glutathione S-transferase, and J18b,
which encodes 293 amino acids of the C-terminal domain, were
generated in Escherichia coli and purified as previously de-
tailed (12, 13). The purity of the isolated protein was assessed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and staining with Coomassie blue, and its spec-
ificity was assessed by immunoblotting with MAb 3F6. An
assay of gp82 binding to mucin from porcine stomach (type III;
Sigma) was performed as follows. Microtiter plates (96 wells)
coated with gastric mucin in phosphate-buffered saline (PBS;
10 g/well) were blocked with PBS containing 10% fetal calf
serum for 1 h at room temperature and then incubated se-
quentially, at 37°C for 1 h, with native or recombinant gp82,
with MAb 3F6 (18) or polyclonal monospecific antibody to
recombinant gp82 (13), and with peroxidase-conjugated anti-
mouse IgG, in PBS containing 10% fetal calf serum. The final
reaction was revealed by o-phenylenediamine as previously
described (10). Binding of recombinant gp82 to HeLa cells was
assayed by enzyme-linked immunosorbent assay (ELISA) as
detailed elsewhere (10). For treatment with the proteolytic
enzymes pepsin (Sigma) and proteinase K (Life Technologies),
parasites were incubated at 37°C for 30 min with the enzymes,
washed three times in PBS, and then used for experiments.
Immunoblotting of parasite extracts was done as detailed else-
where (19), and the final reaction was revealed by diamino-
benzidine plus H2O2. To determine the levels of T. cruzi sur-
face molecules that react with MAb 3F6, live parasites (3 107
cells) were incubated for 1 h on ice with MAb 3F6 or with
unrelated isotype-matched MAb 1C3 directed to Leishmania
amazonensis gp63 (1) and then processed for flow cytometry as
previously described (11).
In preliminary experiments, we ascertained that oral admin-
istration of culture-derived T. cruzi metacyclic trypomastigotes
to BALB/c mice leads to systemic infection. Next, we examined
whether the metacyclic-stage surface molecule gp82 is impli-
cated in mucosal infection. The parasites were preincubated
with gp82-specific MAb 3F6 or with unrelated isotype-matched
MAb 1C3 and then inoculated by the intrapharyngeal route
into BALB/c mice. As the source of antibody, we used ascitic
fluid, which was mixed with the parasite suspension (vol/vol) in
a volume of 100 l. After 30 min of incubation at room tem-
perature, 1.2 ml of PBS was added and 0.2 ml of a parasite
suspension containing 4  105 metacyclic forms was given to
each mouse. Starting on day 13 postinoculation, blood samples
were examined twice a week for the presence of parasites. As
shown in Fig. 1, the parasitemia levels of mice that received
metacyclic forms pretreated with MAb 3F6 were greatly re-
duced compared to those of the control group. At the peak of
parasitemia, control animals suffered from cachexia and one
died at day 25 postinfection. The experiment was repeated and
gave similar results, confirming the infection-blocking activity
of MAb 3F6. We presume that this antibody, which is devoid of
any parasite-agglutinating or -immobilizing effect, acts by
blocking gp82-mediated mucosal cell invasion, provided that
the host cell binding site of gp82 is contiguous to and overlaps
the epitope for MAb 3F6 (8). In addition, experiments were
done to examine the effect of anti-T. cruzi MAbs other than
MAb 3F6 by preincubating metacyclic trypomastigotes with
MAb 1G7, which is directed to metacyclic-stage-specific sur-
face glycoprotein gp90 (18), or with MAb 3C9, which recog-
nizes a sialic acid-containing epitope in trypomastigote glyco-
proteins (14), before oral administration. We found no
inhibitory effect of MAb 1G7 or MAb 3C9 on T. cruzi infec-
tion: both the control and experimental animals developed
high parasitemias, and 20% mortality was observed in all
groups.
According to Hoft et al. (7), the gastric mucosal epithelium
is the portal of T. cruzi entry upon oral challenge of mice with
metacyclic trypomastigotes. By using an immunohistochemical
staining technique specific for intracellular T. cruzi amasti-
gotes, they found no evidence of parasite invasion within the
oropharynx or esophagus, but in multiple experiments, they
found pseudocysts of amastigotes within sections of gastric
mucosa adjacent to the areas of inflammation, and by day 14
postchallenge, motile trypomastigotes were seen in the blood,
indicating that T. cruzi can invade and replicate in the gastric
mucosal epithelium. Adherence of parasites to gastric mucin
FIG. 1. Inhibitory effect of MAb 3F6 on oral T. cruzi infection by
metacyclic trypomastigotes. Parasites pretreated with MAb 3F6 were
given orally to a group of five BALB/c mice. The control group re-
ceived parasites treated with unrelated MAb 1C3. Each datum point
corresponds to the mean parasitemia of five animals in each group of
mice.
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could therefore be a step that precedes invasion. Shigella dys-
enteriae, for instance, whose pathogenic potential is correlated
with its ability to invade and multiply within the cells of the
colonic epithelium, preferentially adheres to colonic mucin
(16). We examined the ability of gp82 to adhere to gastric
mucin. An ELISA was performed by incubating mucin-coated
microtiter plates with either native gp82 or corresponding re-
combinant protein J18. Both molecules bound to gastric mucin
(Fig. 2A). Adhesion of J18b, a recombinant protein corre-
sponding to the gp82 carboxy-terminal domain (amino acids
224 to 516), was also observed. Binding of gp82 to gastric
mucin was dose dependent but not saturable (Fig. 2B), in
contrast to adhesion to HeLa cells (Fig. 2C). To determine
whether the gp82 mucin-binding site resides in the central
region of the molecule, where the host cell binding site is
located (8, 12), we tested a set of 20-mer synthetic peptides
with 10 overlapping residues, spanning the domain comprising
amino acids 224 to 363. Five of these, at 200 g/ml and differ-
ing from the two peptides defined as part of the host cell
binding site (8), exhibited some inhibitory effect on gp82 ad-
hesion to mucin (data not shown). In addition to gp82, two
other metacyclic surface glycoproteins, gp90 and gp35/50, were
tested for binding activity toward gastric mucin. As shown in
Fig. 2B, binding of these molecules to mucin was negligible.
We performed in vitro assays to confirm that gastric mucin
does not interfere with penetration of epithelial cells by meta-
cyclic forms and that MAb 3F6 inhibits parasite invasion in the
presence of mucin. Parasites, either untreated or pretreated
with MAb 3F6 or with control MAb 1C3 for 10 min at room
temperature, were added to epithelial HeLa cells in the ab-
sence or in the presence of 500 g of gastric mucin per ml.
After 1 h of incubation at 37°C, the number of intracellular
parasites in at least 500 Giemsa-stained cells was determined.
Metacyclic forms entered HeLa cells at the same rate whether
mucin was present or not, and pretreatment of parasites with
MAb 3F6, but not with MAb 1C3, significantly inhibited cell
invasion in the presence of gastric mucin (data not shown).
MAbs 1G7 and 3C9, directed, respectively, to T. cruzi gp90 and
mucin-like molecules, were devoid of an inhibitory effect.
To successfully invade the mucosal epithelium, metacyclic
trypomastigotes should resist the acidic pH within the host
stomach and digestion by the proteolytic enzyme pepsin. To
test their resistance to acidic conditions, we incubated para-
sites at different pHs lower than 7.0. At pH 3.5, in citrate
buffer, metacyclic forms remained fully motile and morpholog-
ically indistinguishable from parasites at pH 7.0. When the pH
was lowered to 3.0, some of the parasites lost motility. We
examined their susceptibility to pepsin by treating parasites for
30 min at 37°C with 2 mg of pepsin per ml (optimal activity at
pH 2.0 to 4.0) in citrate buffer at pH 3.5. After washings in
PBS, the parasites were used for cell invasion assays and anal-
ysis by SDS-PAGE and immunoblotting. Pepsin-treated para-
sites showed the same protein profile as the untreated control
and preserved intact the gp82 molecule (Fig. 3A), as well as the
ability to enter HeLa cells (data not shown). Bovine serum
albumin treated with pepsin at pH 3.5 was completely digested,
showing that the enzyme was fully active. In addition to pepsin,
we also tested the effects of other proteolytic enzymes, such as
trypsin, papain, and proteinase K. The results obtained with
trypsin and papain were similar to those obtained with pepsin.
However, when metacyclic forms were treated with 1 mg of
proteinase K per ml (optimal activity at pH 6.5 to 9.5) at pH 7.0
for 30 min at 37°C, we observed extensive protein digestion
and conversion of gp82 to a smaller molecule (35 kDa) that
was still recognized by MAb 3F6 (Fig. 3A). By analyzing the
parasites by flow cytometry, we found that the levels of MAb
FIG. 2. Binding of T. cruzi metacyclic-stage surface molecule gp82 to gastric mucin. (A) gp82, either purified from parasite extracts or as a
recombinant protein containing the entire gp82 peptide sequence (J18) or the C-terminal domain of gp82 (J18b), at 10 g/ml, was added to
microtiter plates coated with porcine gastric mucin. (B) Increasing concentrations of the T. cruzi surface molecule gp90, gp35/50, or gp82, as well
as the recombinant protein J18, were added to wells in microtiter plates coated with gastric mucin. (C) Increasing doses of J18b were added to
plates containing adherent HeLa cells. In all ELISAs, after washes, the plates were sequentially incubated with anti-gp82 antibody, anti-gp90 MAb
1G7, or anti-gp35/50 MAb 10D8 and anti-mouse immunoglobulin conjugated to peroxidase. The bound enzyme was revealed by using o-
phenylenediamine. The values are the means  standard deviations of triplicate samples. O.D.492, optical density at 492 nm.
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3F6-reactive surface molecules were comparable in proteinase
K-treated and untreated samples (Fig. 3B). Recognition by
MAb 3F6 upon proteinase K treatment indicated that the gp82
host cell binding site, which is located contiguous to and down-
stream of the epitope for MAb 3F6 (positions 244 to 263), was
preserved and implied that the enzymatic treatment would not
affect parasite infectivity. Accordingly, proteinase K-treated
metacyclic trypomastigotes invaded HeLa cells at the same
rate as untreated controls (Fig. 3C).
In this study, for the first time, a chemically defined T. cruzi
metacyclic-stage surface molecule was associated with in vivo
infection and invasion of the mucosal epithelium. The finding
that MAb 3F6, which specifically recognizes metacyclic-stage
surface glycoprotein gp82, greatly reduces the systemic T. cruzi
infection resulting from an oral challenge with metacyclic-stage
trypomastigotes (Fig. 1) and also significantly inhibits parasite
entry into epithelial HeLa cells in the presence of gastric mu-
cin, suggests that gp82 is implicated in invasion of the mucosal
FIG. 3. Effects of proteolytic enzymes on T. cruzi metacyclic-stage trypomastigotes. (A) Parasites, untreated or treated with pepsin or proteinase
K, were analyzed by SDS-PAGE, staining with Coomassie blue, and immunoblotting with MAb 3F6. Note the pepsin digestion of bovine serum
albumin, but not of metacyclic-form proteins, including gp82, which were susceptible to proteinase K digestion. (B) Live parasites, untreated ()
or treated with proteinase K (), were reacted with MAb 3F6, fixed, and then analyzed by flow cytometry. (C) Control and proteinase K-treated
metacyclic forms were used for HeLa cell invasion assay. Values represent the means  standard deviation of three experiments.
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epithelium. Before penetrating epithelial cells, metacyclic
forms may engage gp82 to adhere to and traverse the mucin
that lines the gastric mucosal surfaces. Several observations
reinforce that notion. The presence of mucin did not affect the
invasion of HeLa cells by metacyclic forms. gp82 bound to
gastric mucin (Fig. 2), possibly with low affinity and through a
recognition site different from the host cell binding site, so that
adhesion to mucin did not interfere with parasite invasion.
Metacyclic forms resisted an acidic pH and pepsin digestion.
All of these observations are consistent with the ability of
metacyclic trypomastigotes to invade the gastric mucosal epi-
thelium efficiently by engaging the stage-specific surface mol-
ecule gp82.
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